Clinical Trials Update:&nbsp;Dec. 9, 2004
4422
(HealthDayNews) -- Here are the latest clinical trials, courtesy of CenterWatch:
31944
Pharmaceutical giant Pfizer Inc. will  announce plans for a large-scale clinical trial of the ability  of blockbuster drug Celebrex to prevent heart attacks and  strokes in patients with cardiovascular disease, the Wall  Street Journal reported on Monday.
118026
A clinical trial of the blockbuster arthritis drug Celebrex was shut down Friday after researchers found an increase in the risk of serious heart disease and strokes in those taking the drug.
592462
roundup Plus: PC shipments up, but revenue less so, study says...BEA mobilizes corporate data...Web services outfits merge...Microsoft sets holiday Xbox bundle...PalmSource settles Digeo patent suit.
594161
Genzyme announces positive study results with a recently acquired drug.
319964
The embattled pharmaceutical industry announced its intention Thursday to publish more data about clinical drug trials, despite skepticism about whether the initiative will really increase transparency and improve drug safety.
131494
(Undated) Oct. 19, 2004 - The maker of arthritis drug Celebrex is launching a study to see if the drug has the same dangerous side effects that took Vioxx off the market.
511748
Northfield announces clinical trial results that investors can learn from.
306233
THURSDAY, July 5 (HealthDay News) -- New research suggests that the timing of when a woman receives the breast cancer drug Herceptin can influence its effect on her heart.
138871
We have today been informed of new clinical trial data for celecoxib (Celebrex), showing an increased risk of heart attack, stroke and death (relative to placebo).
403859
TUESDAY, Oct. 5 (HealthDayNews) -- A trial for what appeared to be a promising new therapy for Parkinson's disease has been halted, although researchers haven't given up hope that the drug will one day prove useful.
470908
Six months after the drug industry vowed to make its clinical trials more transparent, and three months after launching a common website to give the public "unprecedented access" to studies both good and bad, drug companies have posted unpublished trial results on the site for just five drugs.
383170
Human Genome Sciences, Inc. announced today that it has begun dosing patients in a Phase 2 clinical trial of HGS-ETR1 (agonistic human monoclonal antibody to TRAIL Receptor 1) in patients with advanced ...
621066
Two newly published studies in the September 17, 2004 issue of Science give rise to the possibility of developing drug therapies that target eosinophils, white blood cells long known to be associated with the asthma.
122956
Many clinical cancer trials are not published in order to keep industry secrets. A British cancer research group calls for all studies to be published -- even those with marginal results -- so doctors are not misled.
117982
Robert B. Saper, MD, MPH ; Stefanos N. Kales, MD, MPH ; Janet Paquin, PhD ; Michael J. Burns, MD ; David M. Eisenberg, MD ; Roger B. Davis, ScD ; Russell S. Phillips, MD.
417456
roundup Plus: .Mac customers suffer e-mail glitches...IBM launches business research group...Verbatim to make discs with HP labeling feature.